id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0369-0949,FDA,FDA-2007-D-0369,PSG_214962 - Draft Guidance on Fingolimod Lauryl Sulfate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:46Z,,1,0,0900006486286f24
FDA-2007-D-0369-0953,FDA,FDA-2007-D-0369,PSG_214120 - Draft Guidance on Azacitidine,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f2d
FDA-2007-D-0369-0955,FDA,FDA-2007-D-0369,PSG_214958 - Draft Guidance on Deucravacitinib,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f31
FDA-2007-D-0369-0967,FDA,FDA-2007-D-0369,PSG_215446 - Draft Guidance on Edaravone,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f4a
FDA-2007-D-0369-0933,FDA,FDA-2007-D-0369,PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:44Z,,1,0,0900006486286f00
FDA-2007-D-0369-0938,FDA,FDA-2007-D-0369,PSG_021433 - Draft Guidance on Fluticasone Propionate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:44Z,,1,0,0900006486286f0a
FDA-2007-D-0369-0937,FDA,FDA-2007-D-0369,PSG_014602 - Draft Guidance on Betamethasone Acetate; Betamethasone Sodium Phosphate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:44Z,,1,0,0900006486286f08
FDA-2007-D-0369-0945,FDA,FDA-2007-D-0369,PSG_205641 - Draft Guidance on Mometasone Furoate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:46Z,,1,0,0900006486286f18
FDA-2007-D-0369-0930,FDA,FDA-2007-D-0369,PSG_017643 - Draft Guidance on Soybean Oil,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:43Z,,1,0,0900006486287259
FDA-2007-D-0369-0942,FDA,FDA-2007-D-0369,PSG_206317 - Draft Guidance on Ferric Pyrophosphate Citrate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f12
FDA-2007-D-0369-0960,FDA,FDA-2007-D-0369,PSG_215256 - Draft Guidance on Semaglutide,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:48Z,,1,0,0900006486286f3c
FDA-2007-D-0369-0948,FDA,FDA-2007-D-0369,PSG_209637 - Draft Guidance on Semaglutide,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-12-14T02:00:54Z,,1,0,0900006486286f22
FDA-2007-D-0369-0959,FDA,FDA-2007-D-0369,PSG_215092 - Draft Guidance on Omidenepag Isopropyl,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:48Z,,1,0,0900006486286f3a
FDA-2007-D-0369-0962,FDA,FDA-2007-D-0369,PSG_216903 - Draft Guidance on Glycopyrrolate; Neostigmine Methylsulfate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f40
FDA-2007-D-0369-0928,FDA,FDA-2007-D-0369,PSG_021395 - Draft Guidance on Tiotropium Bromide,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:43Z,,1,0,0900006486287255
FDA-2007-D-0369-0929,FDA,FDA-2007-D-0369,PSG_020503 - Draft Guidance on Albuterol Sulfate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:43Z,,1,0,0900006486287257
FDA-2007-D-0369-0944,FDA,FDA-2007-D-0369,PSG_022544 - Draft Guidance on Gabapentin,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f16
FDA-2007-D-0369-0954,FDA,FDA-2007-D-0369,PSG_209988 - Draft Guidance on Furosemide,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f2f
FDA-2007-D-0369-0935,FDA,FDA-2007-D-0369,PSG_017768 - Draft Guidance on Chlorhexidine Gluconate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:44Z,,1,0,0900006486286f04
FDA-2007-D-0369-0964,FDA,FDA-2007-D-0369,PSG_215401 - Draft Guidance on Dextroamphetamine,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f44
FDA-2007-D-0369-0966,FDA,FDA-2007-D-0369,PSG_216354 - Draft Guidance on Deutetrabenazine,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f48
FDA-2007-D-0369-0958,FDA,FDA-2007-D-0369,PSG_215272 - Draft Guidance on Tapinarof,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:48Z,,1,0,0900006486286f38
FDA-2007-D-0369-0927,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-05-16T20:18:05Z,2023-25485,0,0,090000648628cbd3
FDA-2007-D-0369-0934,FDA,FDA-2007-D-0369,PSG_021344 - Draft Guidance on Fulvestrant,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2023-11-17T20:16:37Z,,0,0,0900006486286f02
FDA-2007-D-0369-0939,FDA,FDA-2007-D-0369,PSG_208551 - Draft Guidance on Ferric Pyrophosphate Citrate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f0c
FDA-2007-D-0369-0947,FDA,FDA-2007-D-0369,PSG_022180 - Draft Guidance on Ferumoxytol,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:46Z,,1,0,0900006486286f20
FDA-2007-D-0369-0957,FDA,FDA-2007-D-0369,PSG_214665 - Draft Guidance on Sotorasib,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:48Z,,1,0,0900006486286f36
FDA-2007-D-0369-0931,FDA,FDA-2007-D-0369,PSG_009170 - Draft Guidance on Primidone,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:43Z,,1,0,0900006486286efc
FDA-2007-D-0369-0946,FDA,FDA-2007-D-0369,PSG_021897 - Draft Guidance on Naltrexone,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:46Z,,1,0,0900006486286f1e
FDA-2007-D-0369-0950,FDA,FDA-2007-D-0369,PSG_209354 - Draft Guidance on Halobetasol Propionate; Tazarotene,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:46Z,,1,0,0900006486286f26
FDA-2007-D-0369-0956,FDA,FDA-2007-D-0369,PSG_212860 - Draft Guidance on Ferric Pyrophosphate Citrate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f34
FDA-2007-D-0369-0963,FDA,FDA-2007-D-0369,PSG_215904 - Draft Guidance on Ganaxolone,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f42
FDA-2007-D-0369-0932,FDA,FDA-2007-D-0369,PSG_020622 - Draft Guidance on Glatiramer Acetate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:43Z,,1,0,0900006486286efe
FDA-2007-D-0369-0941,FDA,FDA-2007-D-0369,PSG_208215 - Draft Guidance on Emtricitabine; Tenofovir Alafenamide Fumarate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f10
FDA-2007-D-0369-0943,FDA,FDA-2007-D-0369,PSG_021730 - Draft Guidance on Levalbuterol Tartrate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f14
FDA-2007-D-0369-0951,FDA,FDA-2007-D-0369,PSG_210655 - Draft Guidance on Risperidone,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f29
FDA-2007-D-0369-0936,FDA,FDA-2007-D-0369,PSG_017920 - Draft Guidance on Cimetidine,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:44Z,,1,0,0900006486286f06
FDA-2007-D-0369-0940,FDA,FDA-2007-D-0369,PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:45Z,,1,0,0900006486286f0e
FDA-2007-D-0369-0952,FDA,FDA-2007-D-0369,PSG_214801 - Draft Guidance on Futibatinib,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:47Z,,1,0,0900006486286f2b
FDA-2007-D-0369-0961,FDA,FDA-2007-D-0369,PSG_216472 - Draft Guidance on Latanoprost,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:48Z,,1,0,0900006486286f3e
FDA-2007-D-0369-0965,FDA,FDA-2007-D-0369,PSG_215428 - Draft Guidance on Citalopram Hydrobromide,Other,Guidance,2023-11-17T05:00:00Z,2023,11,2023-11-17T05:00:00Z,2024-01-17T04:59:59Z,2024-11-12T06:22:49Z,,1,0,0900006486286f46
FDA-2007-D-0369-0887,FDA,FDA-2007-D-0369,PSG_021258 Draft Guidance on Estradiol; Levonorgestrel,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b4e
FDA-2007-D-0369-0891,FDA,FDA-2007-D-0369,PSG_201739 Draft Guidance on Epinephrine,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-08-23T03:59:59Z,2024-11-11T21:31:06Z,,1,0,0900006485ed5b5c
FDA-2007-D-0369-0921,FDA,FDA-2007-D-0369,PSG_216359 Draft Guidance on Midazolam Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:08Z,,1,0,0900006485ed6325
FDA-2007-D-0369-0902,FDA,FDA-2007-D-0369,PSG_020746 Draft Guidance on Budesonide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b46
FDA-2007-D-0369-0888,FDA,FDA-2007-D-0369,PSG_021527 Draft Guidance on Ipratropium Bromide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:06Z,,1,0,0900006485ed5b50
FDA-2007-D-0369-0916,FDA,FDA-2007-D-0369,PSG_216227 Draft Guidance on Chloroprocaine Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,,2024-11-11T21:31:07Z,,1,0,0900006485ed6319
FDA-2007-D-0369-0900,FDA,FDA-2007-D-0369,PSG_008816 Draft Guidance on Lidocaine Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:04Z,,1,0,0900006485ed5b42
FDA-2007-D-0369-0915,FDA,FDA-2007-D-0369,PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:07Z,,1,0,0900006485ed627c
FDA-2007-D-0369-0901,FDA,FDA-2007-D-0369,PSG_020468 Draft Guidance on Triamcinolone Acetonide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b44
FDA-2007-D-0369-0896,FDA,FDA-2007-D-0369,PSG_213433 Draft Guidance on Clascoterone,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:13Z,,1,0,0900006485ed5c47
FDA-2007-D-0369-0905,FDA,FDA-2007-D-0369,PSG_214487 Draft Guidance on Avacopan,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:37Z,,1,0,0900006485ed5c59
FDA-2007-D-0369-0914,FDA,FDA-2007-D-0369,PSG_214662 Draft Guidance on Maralixibat Chloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:40Z,,1,0,0900006485ed5c77
FDA-2007-D-0369-0920,FDA,FDA-2007-D-0369,PSG_215866 Draft Guidance on Tirzepatide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2025-02-23T05:15:13Z,,1,0,0900006485ed6321
FDA-2007-D-0369-0907,FDA,FDA-2007-D-0369,PSG_214103 Draft Guidance on Lumasiran Sodium,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c5d
FDA-2007-D-0369-0911,FDA,FDA-2007-D-0369,PSG_214998 Draft Guidance on Mavacamten,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c71
FDA-2007-D-0369-0904,FDA,FDA-2007-D-0369,PSG_214028 Draft Guidance on Pilocarpine Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:37Z,,1,0,0900006485ed5c4d
FDA-2007-D-0369-0890,FDA,FDA-2007-D-0369,PSG_022004 Draft Guidance on Ciclesonide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:06Z,,1,0,0900006485ed5b5a
FDA-2007-D-0369-0892,FDA,FDA-2007-D-0369,PSG_205920 Draft Guidance on Epinephrine,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:06Z,,1,0,0900006485ed5b5e
FDA-2007-D-0369-0917,FDA,FDA-2007-D-0369,PSG_215888 Draft Guidance on Oteseconazole,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:07Z,,1,0,0900006485ed631b
FDA-2007-D-0369-0919,FDA,FDA-2007-D-0369,PSG_216196 Draft Guidance on Mitapivat Sulfate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,,2024-11-11T21:31:08Z,,1,0,0900006485ed631f
FDA-2007-D-0369-0885,FDA,FDA-2007-D-0369,PSG_020911 Draft Guidance on Beclomethasone Dipropionate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b4a
FDA-2007-D-0369-0903,FDA,FDA-2007-D-0369,PSG_021234 Draft Guidance on Diclofenac Epolamine,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b48
FDA-2007-D-0369-0893,FDA,FDA-2007-D-0369,PSG_208712 Draft Guidance on Pacritinib Citrate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:12Z,,1,0,0900006485ed5c34
FDA-2007-D-0369-0897,FDA,FDA-2007-D-0369,PSG_213137 Draft Guidance on Voxelotor,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:13Z,,1,0,0900006485ed5c49
FDA-2007-D-0369-0906,FDA,FDA-2007-D-0369,PSG_213581 Draft Guidance on Atropine Sulfate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-08-23T03:59:59Z,2024-11-07T01:23:37Z,,1,0,0900006485ed5c5b
FDA-2007-D-0369-0884,FDA,FDA-2007-D-0369,"Product-Specific Guidances; Draft and Revised Draft Guidances for Industry;
Availability",Notice,Notice of Availability,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,,2023-08-22T13:37:43Z,2023-18026,0,0,0900006485ed5264
FDA-2007-D-0369-0886,FDA,FDA-2007-D-0369,PSG_021658 Draft Guidance on Ciclesonide,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:05Z,,1,0,0900006485ed5b4c
FDA-2007-D-0369-0918,FDA,FDA-2007-D-0369,PSG_215358 Draft Guidance on Asciminib Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:08Z,,1,0,0900006485ed631d
FDA-2007-D-0369-0898,FDA,FDA-2007-D-0369,PSG_212097 Draft Guidance on Glucagon,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:40Z,,1,0,0900006485ed5c4b
FDA-2007-D-0369-0909,FDA,FDA-2007-D-0369,PSG_214985 Draft Guidance on Daridorexant Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c61
FDA-2007-D-0369-0895,FDA,FDA-2007-D-0369,PSG_211746 Draft Guidance on Mometasone Furoate; Olopatadine Hydrochloride,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:13Z,,1,0,0900006485ed5c45
FDA-2007-D-0369-0908,FDA,FDA-2007-D-0369,PSG_213871 Draft Guidance on Abrocitinib,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c5f
FDA-2007-D-0369-0912,FDA,FDA-2007-D-0369,PSG_215310 Draft Guidance on Mobocertinib Succinate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-08-23T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c73
FDA-2007-D-0369-0899,FDA,FDA-2007-D-0369,PSG_019389 Draft Guidance on Beclomethasone Dipropionate Monohydrate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:04Z,,1,0,0900006485ed5b27
FDA-2007-D-0369-0889,FDA,FDA-2007-D-0369,PSG_022033 Draft Guidance on Fluvoxamine Maleate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:06Z,,1,0,0900006485ed5b58
FDA-2007-D-0369-0922,FDA,FDA-2007-D-0369,PSG_215515 Draft Guidance on Vutrisiran Sodium,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-11T21:31:08Z,,1,0,0900006485ed6327
FDA-2007-D-0369-0910,FDA,FDA-2007-D-0369,PSG_215206 Draft Guidance on Atogepant,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:38Z,,1,0,0900006485ed5c6f
FDA-2007-D-0369-0894,FDA,FDA-2007-D-0369,PSG_207921 Draft Guidance on Beclomethasone Dipropionate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:12Z,,1,0,0900006485ed5c36
FDA-2007-D-0369-0913,FDA,FDA-2007-D-0369,PSG_215309 Draft Guidance on Ruxolitinib Phosphate,Other,Guidance,2023-08-22T04:00:00Z,2023,8,2023-08-22T04:00:00Z,2023-10-24T03:59:59Z,2024-11-07T01:23:40Z,,1,0,0900006485ed5c75
FDA-2007-D-0369-0867,FDA,FDA-2007-D-0369,PSG_214793 - Draft Guidance on Piflufolastat F-18,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:12Z,,1,0,0900006485a20d0a
FDA-2007-D-0369-0868,FDA,FDA-2007-D-0369,PSG_214916 - Draft Guidance on Difelikefalin Acetate,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-18T03:59:59Z,2024-11-07T01:34:15Z,,1,0,0900006485a20c85
FDA-2007-D-0369-0860,FDA,FDA-2007-D-0369,PSG_213691- Draft Guidance on Clobetasol Propionate,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:19Z,,1,0,0900006485a204e2
FDA-2007-D-0369-0866,FDA,FDA-2007-D-0369,PSG_214783 - Draft Guidance on Belumosudil Mesylate,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:14Z,,1,0,0900006485a20c81
FDA-2007-D-0369-0871,FDA,FDA-2007-D-0369,PSG_215457 - Draft Guidance on Naloxone Hydrochloride,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:13Z,,1,0,0900006485a20c89
FDA-2007-D-0369-0874,FDA,FDA-2007-D-0369,PSG_018152 - Draft Guidance on Lithium Carbonate,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:18Z,,1,0,0900006485a23167
FDA-2007-D-0369-0857,FDA,FDA-2007-D-0369,Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,Notice,Notice of Availability,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,,2023-05-19T15:39:54Z,2023-10710,0,0,0900006485a22a81
FDA-2007-D-0369-0865,FDA,FDA-2007-D-0369,PSG_214461 - Draft Guidance on Brincidofovir,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:14Z,,1,0,0900006485a2057a
FDA-2007-D-0369-0863,FDA,FDA-2007-D-0369,PSG_214410 - Draft Guidance on Baloxavir Marboxil,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:11Z,,1,0,0900006485a20577
FDA-2007-D-0369-0875,FDA,FDA-2007-D-0369,PSG_018558 - Draft Guidance on Lithium Carbonate,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:18Z,,1,0,0900006485a23169
FDA-2007-D-0369-0858,FDA,FDA-2007-D-0369,PSG_213312 Draft Guidance on Sirolimus,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:10Z,,1,0,0900006485a1e362
FDA-2007-D-0369-0861,FDA,FDA-2007-D-0369,PSG_213026 - Draft Guidance on Casimersen,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:14Z,,1,0,0900006485a20573
FDA-2007-D-0369-0862,FDA,FDA-2007-D-0369,PSG_214012- Draft Guidance on Inclisiran Sodium,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:14Z,,1,0,0900006485a20575
FDA-2007-D-0369-0876,FDA,FDA-2007-D-0369,PSG_207925 - Draft Guidance on Ivacaftor,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:14Z,,1,0,0900006485a2283a
FDA-2007-D-0369-0872,FDA,FDA-2007-D-0369,PSG_211911- Draft Guidance on Bimatoprost,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:22Z,,1,0,0900006485a22d9c
FDA-2007-D-0369-0869,FDA,FDA-2007-D-0369,PSG_215341- Draft Guidance on Finerenone,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:16Z,,1,0,0900006485a20d0d
FDA-2007-D-0369-0864,FDA,FDA-2007-D-0369,PSG_214460 - Draft Guidance on Brincidofovir,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:12Z,,1,0,0900006485a204e5
FDA-2007-D-0369-0870,FDA,FDA-2007-D-0369,PSG_215383 - Draft Guidance on Belzutifan),Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:16Z,,1,0,0900006485a20d0f
FDA-2007-D-0369-0873,FDA,FDA-2007-D-0369,PSG_212194 -Draft Guidance on Givosiran Sodium,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:09Z,,1,0,0900006485a22802
FDA-2007-D-0369-0859,FDA,FDA-2007-D-0369,PSG_213426 - Draft Guidance on Celecoxib; Tramadol Hydrochloride,Other,Guidance,2023-05-19T04:00:00Z,2023,5,2023-05-19T04:00:00Z,2023-07-19T03:59:59Z,2024-11-07T01:34:07Z,,1,0,0900006485a20571